Bone Metabolism and Turnover

Bone Cells & ECM - Tiny Bone Builders

• Osteoblasts: Bone-forming cells from MSCs.
  • Synthesize osteoid (unmineralized matrix): Type I collagen, osteocalcin.
  • Marker: Alkaline Phosphatase (ALP).
• Osteocytes: Mature osteoblasts in lacunae; mechanosensors.
  • Regulate osteoblast/osteoclast activity.

  ⭐ Osteocytes are the most abundant bone cells (90-95%), acting as master regulators.

• Osteoclasts: Bone-resorbing multinucleated cells from hematopoietic stem cells (monocyte-macrophage).
  • In Howship's lacunae; create acidic environment.
  • Markers: TRAP, Cathepsin K.
• Bone Lining Cells: Quiescent osteoblast derivatives on resting bone surfaces.
• Extracellular Matrix (ECM):
  • Organic (~35%): Type I collagen (tensile strength), proteoglycans.
  • Inorganic (~65%): Hydroxyapatite $Ca_{10}(PO_4)_6(OH)_2$ (compressive strength).

Bone Remodeling Cycle - Renew & Rebuild

Continuous, lifelong physiological process where old or damaged bone is resorbed and replaced by new, healthy bone. Essential for skeletal integrity, micro-damage repair, and calcium/phosphorus homeostasis. Orchestrated by Basic Multicellular Units (BMUs).

📌 Mnemonic for phases: ARRF-Q (Activation, Resorption, Reversal, Formation, Quiescence)

• Key Cells:
  • Osteoclasts (OCs): Resorb bone (Howship's lacunae). Stimulated by RANKL.
  • Osteoblasts (OBs): Form new bone (osteoid). Promote OPG to inhibit OCs.
• Coupling: Resorption & formation tightly linked; imbalance leads to bone pathology.
• Duration: Cycle ~4-6 months (trabecular); significantly longer for cortical bone.
• Key Regulators: PTH, Vitamin D, Calcitonin, Estrogen, androgens, mechanical load.

⭐ The OPG/RANKL ratio is pivotal: ↑OPG/RANKL favors bone formation by inhibiting osteoclastogenesis, ↓OPG/RANKL favors resorption.

Hormonal Control Tower - Bone's Bosses

• Parathyroid Hormone (PTH): Chief Ca²⁺ regulator. 📌 PTH = Phosphate Trashing Hormone (↓ renal PO₄³⁻ reabsorption) & Pushes The Calcium High.
  • Source: Parathyroid glands.
  • Action: ↑ serum Ca²⁺, ↓ serum PO₄³⁻.
  • Bone: Primarily ↑ resorption (indirectly, via RANKL on osteoblasts stimulating osteoclasts).
  • Kidney: ↑ Ca²⁺ reabsorption, ↓ PO₄³⁻ reabsorption, ↑ $1,25(OH)_2D_3$ synthesis.
• Vitamin D (Calcitriol - $1,25(OH)_2D_3$): Ca²⁺ & PO₄³⁻ absorption champion.
  • Source: Skin (UV), diet; activated in liver (25-OH) then kidney ($1,25(OH)_2D_3$).
  • Action: ↑ serum Ca²⁺ & ↑ serum PO₄³⁻.
  • Intestine: Major site for ↑ Ca²⁺ & PO₄³⁻ absorption.
  • Bone: Promotes mineralization; regulates osteoblast/osteoclast activity.
• Calcitonin: "Tones down" serum Ca²⁺.
  • Source: Thyroid C-cells (parafollicular cells).
  • Action: ↓ serum Ca²⁺ (minor physiological role in humans).
  • Bone: ↓ osteoclast activity.
• Other Influencers:
  • Estrogen: ↓ bone resorption (protects bone). Deficiency → osteoporosis.
  • Glucocorticoids (chronic excess): ↓ bone formation, ↑ bone resorption → osteoporosis.
  • Growth Hormone (GH)/IGF-1: Stimulate bone formation & longitudinal growth.
  • Thyroid Hormones (T3/T4): Essential for skeletal development; excess → ↑ turnover, net bone loss.

⭐ PTH exhibits a dual effect: continuous high levels promote bone resorption, whereas intermittent low-dose administration (e.g., Teriparatide) is anabolic, stimulating bone formation and is used to treat osteoporosis.

Key Minerals & Markers - CaP & Clues

• Key Minerals:
  • Calcium (Ca): Serum 8.5-10.5 mg/dL; Ionized 4.5-5.6 mg/dL (active).
  • Phosphorus (P): Serum 2.5-4.5 mg/dL.
  • Ca x P product: > 55-60 mg²/dL² → ↑ risk soft tissue calcification.
• Bone Formation Markers (Osteoblast ↑):
  • Alkaline Phosphatase (ALP): Total & Bone-Specific (BSAP).
  • Osteocalcin (OC).
  • Procollagen type I N-terminal propeptide (PINP).
• Bone Resorption Markers (Osteoclast ↑):
  • C-telopeptide of type I collagen (CTX) - serum/urine.
  • N-telopeptide of type I collagen (NTX) - urine.
  • Tartrate-Resistant Acid Phosphatase (TRAP 5b).

⭐ PINP (formation) and CTX (resorption) are highly sensitive Bone Turnover Markers (BTMs).

High‑Yield Points - ⚡ Biggest Takeaways

• Wolff's Law: Bone remodels based on applied load.
• Osteoblasts (bone formation) are identified by ALP and Osteocalcin.
• Osteoclasts (resorb bone), marked by TRAP, are regulated by RANKL/OPG.
• PTH elevates serum Ca²⁺ by stimulating osteoclasts; Calcitonin has the opposite effect.
• Vitamin D is essential for calcium absorption and bone mineralization.
• Estrogen deficiency accelerates bone resorption, leading to postmenopausal osteoporosis.
• Bisphosphonates and Denosumab are key drugs inhibiting osteoclast function.